
    
      The primary objective of the clinical investigation Visceral Manifold and Unitary Device
      Study is to assess the use of the thoracic bifurcation and the visceral manifold or the
      unitary stent graft system to repair thoracoabdominal aortic aneurysms in patients having
      appropriate anatomy. The primary intent of the study is to assess safety (i.e. freedom from
      major adverse events (MAE) at 30 days) and preliminary effectiveness (i.e., treatment success
      and technical success) of the device (i.e., the proportion of treatment group subjects that
      achieve and maintain treatment success at one year). Additionally, the study will assess
      technical success and treatment success at each follow-up interval.
    
  